Related Experiment Videos
The EVI1 gene in myeloid leukemia
1Oncology Institute and Department of Microbiology and Immunology, Loyola University Medical Center, Maywood, IL 60153, USA.
Leukemia
|February 3, 1998
Summary
Genetic abnormalities in myeloid leukemia involve the MDS1 and EVI1 genes at chromosome 3q26. These genes, rearranged in leukemia, can function as transcription factors with opposing roles, influencing disease progression.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Leukemia is a genetic disorder characterized by chromosomal abnormalities.
- Recurrent translocations and inversions at chromosome band 3q26 are common in myeloid leukemias.
- The MDS1 and EVI1 genes are located at 3q26 and are implicated in myeloid leukemia development.
Purpose of the Study:
- To review current information on the MDS1 and EVI1 genes.
- To discuss the involvement of these genes in myeloid leukemia.
- To explore the functions of MDS1, EVI1, and their fusion protein MDS1/EVI1.
Main Methods:
- Review of existing scientific literature on MDS1 and EVI1.
- Analysis of chromosomal rearrangements, specifically translocations and inversions at 3q26.
- Examination of gene expression patterns and protein functions.
Main Results:
- MDS1 and EVI1 genes are rearranged in myeloid leukemias, often forming fusion genes with AML1 or TEL.
- These genes can be expressed separately or as a single MDS1/EVI1 fusion protein.
- EVI1 and MDS1/EVI1 act as transcription factors with opposing functions.
Conclusions:
- The MDS1 and EVI1 genes play a significant role in the pathogenesis of myeloid leukemia.
- Aberrant expression and rearrangement of these genes contribute to leukemia development.
- Understanding the distinct functions of EVI1 and MDS1/EVI1 is crucial for leukemia research.